ZA764516B - 2,6-anthraquinonylene amidines as antiamebic agents - Google Patents

2,6-anthraquinonylene amidines as antiamebic agents

Info

Publication number
ZA764516B
ZA764516B ZA764516A ZA764516A ZA764516B ZA 764516 B ZA764516 B ZA 764516B ZA 764516 A ZA764516 A ZA 764516A ZA 764516 A ZA764516 A ZA 764516A ZA 764516 B ZA764516 B ZA 764516B
Authority
ZA
South Africa
Prior art keywords
anthraquinonylene
amidines
antiamebic agents
antiamebic
agents
Prior art date
Application number
ZA764516A
Other languages
English (en)
Inventor
P Fabio
Y Lin
S Lang
K Murdock
T Fields
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA764516B publication Critical patent/ZA764516B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/195Radicals derived from nitrogen analogues of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA764516A 1975-08-22 1976-07-27 2,6-anthraquinonylene amidines as antiamebic agents ZA764516B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60680575A 1975-08-22 1975-08-22

Publications (1)

Publication Number Publication Date
ZA764516B true ZA764516B (en) 1977-07-27

Family

ID=24429543

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA764516A ZA764516B (en) 1975-08-22 1976-07-27 2,6-anthraquinonylene amidines as antiamebic agents

Country Status (21)

Country Link
JP (1) JPS5225763A (el)
AR (1) AR213625A1 (el)
AU (1) AU508586B2 (el)
BE (1) BE845369A (el)
CA (1) CA1098127A (el)
CS (1) CS212773B2 (el)
DE (1) DE2637544A1 (el)
EG (1) EG12401A (el)
ES (1) ES450859A1 (el)
FR (1) FR2321281A1 (el)
GB (1) GB1553600A (el)
GR (1) GR60420B (el)
HU (1) HU173298B (el)
LU (1) LU75636A1 (el)
NL (1) NL7609230A (el)
NZ (1) NZ181596A (el)
PH (1) PH13216A (el)
PL (1) PL191945A1 (el)
PT (1) PT65506B (el)
SU (1) SU883002A1 (el)
ZA (1) ZA764516B (el)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154489B (de) * 1961-05-05 1963-09-19 Basf Ag Verfahren zur Trennung von Mono- und Diaminoanthrachinonen

Also Published As

Publication number Publication date
AR213625A1 (es) 1979-02-28
FR2321281A1 (fr) 1977-03-18
GR60420B (en) 1978-05-25
PL191945A1 (pl) 1978-12-04
PH13216A (en) 1980-02-07
NZ181596A (en) 1978-12-18
GB1553600A (en) 1979-09-26
PT65506B (en) 1978-02-15
JPS5225763A (en) 1977-02-25
HU173298B (hu) 1979-04-28
AU508586B2 (en) 1980-03-27
CS212773B2 (en) 1982-03-26
FR2321281B1 (el) 1979-07-27
EG12401A (en) 1980-03-31
BE845369A (fr) 1977-02-21
NL7609230A (nl) 1977-02-24
PT65506A (en) 1976-09-01
SU883002A1 (ru) 1981-11-23
CA1098127A (en) 1981-03-24
DE2637544A1 (de) 1977-03-03
AU1669376A (en) 1978-02-16
LU75636A1 (el) 1977-03-29
ES450859A1 (es) 1978-04-01

Similar Documents

Publication Publication Date Title
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
GB1549691A (en) 1,1,1-trihalo-4-methyl-(3-or 4)-pentenes
IL50792A0 (en) Herbicidal 1,4-diphenyl-3-pyrazolin-5-ones
NZ183651A (en) Tribalo-n-alkyl-2',4',6'-trinitrodiphenylamines
GB1532697A (en) 2,3-dihydroergolines
PH14168A (en) 2,4-pyrrolidinediones
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
GB1557694A (en) 2,9 dichlorquinacridone
EG12183A (en) 2-chloro-n-isoproyl-2',3'-imethylacetanilide
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
GB1554021A (en) 4,5-didehydroprostaglandins
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
AU504124B2 (en) l-ACYL-l, 2, 3, 4-TETRAHYDRO-6-QUINOLINOLS AND THEIR USE AS ANTIAMEBIC AGENTS
GB1554925A (en) 2,3-methyl-eneprostaglandins
ZA766301B (en) Substituted 2,1,3-benzothiadiazine
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
AU1483576A (en) 16,16-dimethyl-prostaglandins
ZA764516B (en) 2,6-anthraquinonylene amidines as antiamebic agents
PH16286A (en) 1,2-dihydro-6-phenyl-1h,4h-imidazo-benzodiazepin-1-ones
AU1346176A (en) 1,2,3,4-tetrahydro-4-oxo-%or-oxy-<-1-naphthylureas
GB1541079A (en) 2-heterocyclylalkyl-3,3a,4,5,6,7-hexa hydro-3-phenyl-7-benzylidene-2h-indazoles
GB1551409A (en) 3,5-diphenylpyridazine derivatives
ZA76568B (en) 1,3-dialkyl-7-oxoalkylxanthines